StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJul 7, 2026, 05:12 PM

Z Squared Inc. to Offer $300M Common Stock via ATM Facility

AI Summary

Z Squared Inc. entered into a Sales Agreement with Roth Capital Partners, LLC, allowing the company to offer and sell shares of its common stock through an "at the market" offering. The aggregate offering price for these shares can be up to $300,000,000. The sales will be made under an automatic shelf registration statement on Form S-3, with the agent receiving a 3.0% commission on gross sales.

Key Highlights

  • Entered Sales Agreement with Roth Capital Partners, LLC.
  • May offer common stock with an aggregate price up to $300,000,000.
  • Offering will be an "at the market" (ATM) facility.
  • Agent will receive a commission of 3.0% of gross sales price.
  • Sales made pursuant to an automatic shelf registration statement on Form S-3.